Skip to main content
Home / International Journal of Oncology, Volume 46, Number 4
The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.

Publisher: Spandidos Publications

More about this publication?
Volume 46, Number 4, 2015

Articles

Update on Epstein-Barr virus and gastric cancer (Review)
pp. 1421-1434(14)
Authors: Shinozaki-Ushiku; Kunita; Fukayama

Favourites:
ADD

Molecular basis of carcinogenesis in diabetic patients (Review)
pp. 1435-1443(9)
Authors: Matyszewski; Czarnecka; Solarek; Korzeń; Safir; Kukwa; Szczylik

Favourites:
ADD

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)
pp. 1444-1452(9)
Authors: Guo; Teng

Favourites:
ADD

γtocotrienol prevents 5FUinduced reactive oxygen species production in human oral keratinocytes through the stabilization of 5FUinduced activation of Nrf2
pp. 1453-1460(8)
Authors: Takano; Momota; Kani; Aota; Yamamura; Yamanoi; Azuma

Favourites:
ADD

Slug contributes to cancer progression by direct regulation of ERα signaling pathway
pp. 1461-1472(12)
Authors: Li; Wu; Abbatiello; Wu; Kim; Sarkissyan; Sarkissyan; Chung; Elshimali; Vadgama

Favourites:
ADD

A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer
pp. 1473-1480(8)
Authors: Sakamoto; Kodani; Takata; Chikumi; Nakamoto; Nishii-Ito; Ueda; Izumi; Makino; Touge; Takeda; Yamasaki; Yanai; Tanaka; Igishi; Shimizu

Favourites:
ADD

New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane
pp. 1481-1490(10)
Authors: Hole; Pedersen; Hansen; Lundqvist; Yde; Lykkesfeldt

Favourites:
ADD

Gallic acid exerts a protective or an anti-proliferative effect on glioma T98G cells via dose-dependent epigenetic regulation mediated by miRNAs
pp. 1491-1497(7)
Authors: Paolini; Curti; Pasi; Mazzini; Nano; Capelli

Favourites:
ADD

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
pp. 1498-1506(9)
Authors: Umene; Yanokura; Banno; Irie; Adachi; Iida; Nakamura; Nogami; Masuda; Kobayashi; Tominaga; Aoki

Favourites:
ADD

(-)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation
pp. 1507-1515(9)
Authors: Wang; Xie; Feng; Zhang; Huang; Shen; Luo

Favourites:
ADD

Antimicrobial peptide FF/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile
pp. 1516-1526(11)
Authors: Kuroda; Fukuda; Isogai; Okumura; Krstic-Demonacos; Isogai

Favourites:
ADD

Significance of SALL4 as a drugresistant factor in lung cancer
pp. 1527-1534(8)
Authors: Yanagihara; Kobayashi; Kuribayashi; Tanaka; Hasegawa; Watanabe

Favourites:
ADD

Longterm exposure to leptin enhances the growth of prostate cancer cells
pp. 1535-1542(8)
Authors: Noda; Kikugawa; Tanji; Miura; Asai; Higashiyama; Yokoyama

Favourites:
ADD

Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells
pp. 1543-1550(8)
Authors: Iwasaki; Tanaka; Kawano; Itonaga; Tsumura

Favourites:
ADD

The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells
pp. 1551-1559(9)
Authors: Ying; Tsujii; Kondo; Hayashi; Kato; Akasaka; Inoue; Shiraishi; Inoue; Hiyama; Tsujii; Maekawa; Kawai; Fujinaga; Araki; Shinzaki; Watabe; Nishida; Iijima; Takehara

Favourites:
ADD

CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells
pp. 1560-1572(13)
Authors: Ishikura; Kawata; Nishimoto; Nakamura; Tsunenari; Watanabe; Tachibana; Shiraishi; Yoshino; Honma; Emura; Ohta; Nakagawa; Houjo; Corey; Vessella; Aoki; Sato

Favourites:
ADD

Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma
pp. 1573-1581(9)
Authors: Takaya; Peng; Ishino; Kudo; Yamamoto; Wada; Takeshita; Naito

Favourites:
ADD

Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases
pp. 1582-1588(7)
Authors: Jing; Kim; Kim; Kim; Lee; Kim

Favourites:
ADD

Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes
pp. 1589-1600(12)
Authors: Zhang; Han; Wei; Shi; Pu; Zhang; Yuan; Kang

Favourites:
ADD

miR27a suppresses the clonogenic growth and migration of human glioblastoma multiforme cells by targeting BTG2
pp. 1601-1608(8)
Authors: Li; Yu; Zhong; Hou; Li; He; Liu; Xia; Lu

Favourites:
ADD

Activation of PKCδ in HTLV1infected T cells
pp. 1609-1618(10)
Authors: Mori; Ishikawa; Senba

Favourites:
ADD

The anthraquinone derivative Emodin inhibits angiogenesis and metastasis through downregulating Runx2 activity in breast cancer
pp. 1619-1628(10)
Authors: Ma; Lu; Wang; Chen; Liu; Ke; Liu; Fu

Favourites:
ADD

Proapoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells
pp. 1629-1636(8)
Authors: Harati; Slodnik; Chromik; Behr; Goertz; Hirsch; Kapalschinski; KleinHitpass; Kolbenschlag; Uhl; Lehnhardt; Daigeler

Favourites:
ADD

Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer
pp. 1637-1642(6)
Authors: Kluth; Galal; Krohn; Weischenfeldt; Tsourlakis; Paustian; Ahrary; Ahmed; Scherzai; Meyer; Sirma; Korbel; Sauter; Schlomm; Simon; Minner

Favourites:
ADD

β-catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression
pp. 1643-1650(8)
Authors: Zhao; Zhang; Liu; Wang; Zhang; Li

Favourites:
ADD

GDC-0152 attenuates the malignant progression of osteosarcoma promoted by ANGPTL2 via PI3K/AKT but not p38MAPK signaling pathway
pp. 1651-1658(8)
Authors: Yang; Shu; Liang; Gu; Wang; Song; Fan; Wang

Favourites:
ADD

Naphthazarin enhances ionizing radiation-induced cell cycle arrest and apoptosis in human breast cancer cells
pp. 1659-1666(8)
Authors: Kim; Park; Shim; Yang; Kang; Heo

Favourites:
ADD

Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression
pp. 1667-1676(10)
Authors: Shan; Aziz; Tian; Wang; Yan; Liu

Favourites:
ADD

Fra1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro
pp. 1677-1684(8)
Authors: Xiao; Zhou; Yi; Luo; Jiang; Tian; Li; Xue

Favourites:
ADD

Bleb formation is induced by alkaline but not acidic pH in estrogen receptor silenced breast cancer cells
pp. 1685-1698(14)
Authors: Khajah; Mathew; Alam-Eldin; Luqmani

Favourites:
ADD

Immune responses in patients with esophageal cancer treated with SART1 peptidepulsed dendritic cell vaccine
pp. 1699-1709(11)
Authors: Narita; Kanda; Abe; Uchiyama; Iwafuchi; Zheng; Liu; Kaifu; Kosugi; Minagawa; Itoh; Takahashi

Favourites:
ADD

RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9
pp. 1710-1720(11)
Authors: Liu; Dou; Jia; Li; Zheng; Yao; Liu; Song

Favourites:
ADD

EGFstimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinibresistant human lung cancer cell line
pp. 1721-1729(9)
Authors: Nishimura; Takiguchi; Ito; Itoh

Favourites:
ADD

Ellagic acid induces cell cycle arrest and apoptosis through TGF-β/Smad3 signaling pathway in human breast cancer MCF-7 cells
pp. 1730-1738(9)
Authors: Chen; Bai; Zhang; Li; Liu

Favourites:
ADD

Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways
pp. 1739-1747(9)
Authors: Wang; Dai; Yu; Jia; Zhang; Huang; Kang; Jiang; Pu

Favourites:
ADD

iTRAQ-based quantitative proteomic analysis of cervical cancer
pp. 1748-1758(11)
Authors: Ding; Yang; She; Min; Xv; Ran; Wu; Wang; Wang; Yi; Yang; Gao

Favourites:
ADD

Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin-like growth factor 2 imprinting
pp. 1759-1767(9)
Authors: Sun; Pan; He; Deng; Li; Xu; Chen; Gao; Ying; Wang; Liu; Wang

Favourites:
ADD

Dlx-2 is implicated in TGF-β- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by Snail activation
pp. 1768-1780(13)
Authors: Lee; Jeon; Ju; Jeong; Kim; Yoo; Park; Han; Kang

Favourites:
ADD

A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells
pp. 1781-1787(7)
Authors: Nishii; Yamaguchi; Kimura; Hasegawa; Aburatani; Uchida; Hirata; Sakuma

Favourites:
ADD

Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer
pp. 1788-1800(13)
Authors: Liao; Kuo; Lu; Wang; Wu

Favourites:
ADD

Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models
pp. 1801-1809(9)
Authors: Takahashi; Honma; Miyake; Adachi; Takami; Okada; Kumanomidou; Ikejiri; Jo; Onishi; Kawakami; Moriyama; Inoue; Tanaka; Suzumiya

Favourites:
ADD

Molecular response of 4T1-induced mouse mammary tumours and healthy tissues to zinc treatment
pp. 1810-1818(9)
Authors: Sztalmachova; Gumulec; Raudenska; Polanska; Holubova; Balvan; Hudcova; Knopfova; Kizek; Adam; Babula; Masarik

Favourites:
ADD

Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: A comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data
pp. 1819-1826(8)
Authors: Liu; Zhang; Franzin; Cormier; Chan; Xu; Du

Favourites:
ADD

Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention
pp. 1827-1834(8)
Authors: Thakkar; Chenreddy; Wang; Prabhu

Favourites:
ADD

Chrysin inhibits cell invasion by inhibition of Recepteur d'origine Nantais via suppressing early growth response-1 and NF-κB transcription factor activities in gastric cancer cells
pp. 1835-1843(9)
Authors: Xia; Lian; Khoi; Yoon; Han; Chay; Kim; Jung

Favourites:
ADD

Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer
pp. 1844-1848(5)
Authors: Toge; Yokoyama; Kato; Sakurai; Senda; Doki; Hayakawa; Yoshimura; Saiki

Favourites:
ADD

Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells
pp. 1849-1857(9)
Authors: Somasagara; Deep; Shrotriya; Patel; Agarwal; Agarwal

Favourites:
ADD

[Corrigendum] Human β-defensin-3 inhibits migration of colon cancer cells via downregulation of metastasis-associated 1 family, member 2 expression
pp. 1858-1858(1)
Authors: Uraki; Sugimoto; Shiraki; Tameda; Inagaki; Ogura; Kasai; Nojiri; Yoneda; Yamamoto; Takei; Nobori; Ito

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content